Invex Therapeutics Ltd. Financial Overview
Invex Therapeutics Ltd.'s market cap is currently AU$8.64M. The company's EPS TTM is AU$-0.002; its P/E ratio is -18.25; Invex Therapeutics Ltd. is scheduled to report earnings on August 10, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
